Jinchul Kim
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Advances in T-Cell-Directed Immunotherapy for Adult Mature B-Cell Lymphoma: A Comprehensive Review of CAR T-Cell and Bispecific Antibody Therapies.
Journal: Cancer research and treatment
Published: April 23, 2025
Relative efficacy of systemic treatments for patients with relapsed/refractory chronic lymphocytic leukemia: a network meta-analysis according to 17p deletion/TP53 mutations.
Journal: Blood research
Published: August 06, 2024
Investigation of the myopic outcomes of the newer intraocular lens power calculation formulas in Korean patients with long eyes.
Journal: Scientific reports
Published: March 02, 2024
Comparison of the formula accuracy for calculating multifocal intraocular lens power: a single center retrospective study in Korean patients.
Journal: Scientific reports
Published: November 17, 2023
Efficacy of Salvage Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Including Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review and Meta-Analysis.
Journal: Cancer research and treatment
Published: December 26, 2022
Machine Learning Algorithms Predict Successful Weaning From Mechanical Ventilation Before Intubation: Retrospective Analysis From the Medical Information Mart for Intensive Care IV Database.
Journal: JMIR formative research
Published: December 02, 2022
Association of Smoking Status with Efficacy of First-line Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancers: A Systematic Review and Meta-analysis.
Journal: Journal of Cancer
Published: July 26, 2021
Comparison of first-line treatments of peripheral T-cell lymphoma according to regimen: A systematic review and meta-analysis.
Journal: Hematological oncology
Published: June 30, 2021
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell lung cancer.
Journal: Investigational new drugs
Published: February 16, 2021
Prognostic Factors of Survival with Aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) as Second-line Therapy for Patients with Metastatic Colorectal Cancer.
Journal: Journal of Cancer
Published: June 07, 2020
Last Updated: 09/26/2026